0
Skip to Content
Health Business Group
Services ▾
Growth Strategy
Due Diligence for Transactions
Sectors ▾
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
About ▾
Consultants
Case Studies
History
Testimonials
Media Room
blog
Contact
Health Business Group
Services ▾
Growth Strategy
Due Diligence for Transactions
Sectors ▾
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
About ▾
Consultants
Case Studies
History
Testimonials
Media Room
blog
Contact
Folder: Services ▾
Back
Growth Strategy
Due Diligence for Transactions
Folder: Sectors ▾
Back
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
Folder: About ▾
Back
Consultants
Case Studies
History
Testimonials
Media Room
blog
Contact
Pharma, Research 4/9/08 Pharma, Research 4/9/08

Harsh toke

Read More
Economics, Pharma, Policy and politics 4/7/08 Economics, Pharma, Policy and politics 4/7/08

Drug recycling: not much of a solution

Read More
Pharma, Research 4/2/08 Pharma, Research 4/2/08

Does someone who participates in a clinical trial make as big a contribution as an organ donor?

Read More
Economics, Health plans, Pharma 3/21/08 Economics, Health plans, Pharma 3/21/08

Ripple effects of Wal-Mart's $4 generics

Read More
Economics, Pharma 3/19/08 Economics, Pharma 3/19/08

Why not try a software licensing model for chronic meds?

Read More
Pharma 3/18/08 Pharma 3/18/08

Dr. Jekyll and Mr. Malarone

Read More
Pharma, Policy and politics 3/17/08 Pharma, Policy and politics 3/17/08

Another silly bio-generics bill

Read More
Devices, Pharma 3/13/08 Devices, Pharma 3/13/08

Too bad there's no inhaled insulin to go with it

Read More
Pharma, Physicians, Policy and politics 3/11/08 Pharma, Physicians, Policy and politics 3/11/08

MedAdNews (and me) on restrictions on drug marketing

Read More
Pharma, Research 3/9/08 Pharma, Research 3/9/08

How's this for direct to consumer?

Read More
Entrepreneurs, Pharma 3/6/08 Entrepreneurs, Pharma 3/6/08

New product development opportunity: Colon-brite

Read More
Patients, Pharma, Physicians 1/25/08 Patients, Pharma, Physicians 1/25/08

Tales of a PWD PSR, aka a diabetic drug rep

Read More
Entrepreneurs, Pharma 1/21/08 Entrepreneurs, Pharma 1/21/08

iCardiac Technologies: already a Rochester success story

Read More
International, Pharma, Policy and politics 1/15/08 International, Pharma, Policy and politics 1/15/08

Euro folly on drug pipelines

Read More
Economics, Pharma 1/15/08 Economics, Pharma 1/15/08

Applying a software licensing model to pharmaceuticals

Read More
Pharma, Policy and politics 1/10/08 Pharma, Policy and politics 1/10/08

Second time's (not much more of) a charm for PhRMA

Read More
International, Pharma 1/4/08 International, Pharma 1/4/08

MedAdNews (and me) on drug reimportation

Read More
Pharma, Policy and politics, Research 1/3/08 Pharma, Policy and politics, Research 1/3/08

Drug samples not going to the poor. So what?

Read More
Pharma, Policy and politics 12/20/07 Pharma, Policy and politics 12/20/07

Genentech and ophtalmologists now see eye to eye on Avastin

Read More
International, Pharma 12/17/07 International, Pharma 12/17/07

Free trade in counterfeit drugs

Read More
Newer Posts
Older Posts

SERVICES

Growth StrategyDue Diligence for Transactions

SECTORS

Tech-enabled Healthcare Services
Life Sciences

Digital Health and Health IT
Private Equity/Investors

ABOUT

Consultants
Case Studies
History
Testimonials

Media Room
Blog
Contact

101 Federal St., S. 1900 | Boston, MA 02110 | (617) 731-3182

© 2024 Health Business Group. All Rights Reserved.